The aim of the study was to examine the possible tumor growth-promoting effect of treatment with HI, X10 and IGF-1 in a murine colon cancer allografts model (MC38 cells) established in mice with diet-induced obesity (DIO) and insulin resistance. Here, IGF1 is linked to neoplasm.